Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate

ClinicalTrials.gov ID: NCT02387762

Public ClinicalTrials.gov record NCT02387762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 10:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, 4-Week, Double-Blind, Proof-of-Concept Efficacy and Safety Study of ACP-196 Versus Placebo in Subjects With Active Rheumatoid Arthritis on Background Methotrexate

Study identification

NCT ID
NCT02387762
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Acerta Pharma BV
Industry
Enrollment
31 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • acalabrutinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2015
Primary completion
Apr 30, 2016
Completion
May 31, 2016
Last update posted
Apr 1, 2019

2015 – 2016

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207
Achieve Clinical Research Birmingham Alabama 35216
Advanced Arthritis Care and Research Scottsdale Arizona 85258
TriWest Research Associates, LLC El Cajon California 92020
Neuropsychiatric Research Center of Orange County Orange California 92868
Pacific Arthritis Center Medical Group Santa Monica California 93454
Inland Rheumatology and Osteoporosis Medical Group, Inc Upland California 91786
San Marcus Research Clinic, Inc. Hialeah Florida 33015
Suncoast Clinical Research, Inc. New Port Richey Florida 34652
Suncoast Clinical Research New Port Richey Florida 34652
The Arthritis Center Palm Harbor Florida 34684-3176
Office of George Timothy Kelly, MD Las Vegas Nevada 89128
PMG Research of Salisbury Salisbury North Carolina 28144
Health Research of Oklahoma Oklahoma City Oklahoma 73103-2433
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Ramesh C. Gupta, MD Memphis Tennessee 38119
Clear Lake Regional Medical Center Webster Texas 77598

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02387762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2019 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02387762 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →